UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 44

Sortiert nach

Efficacy and safety of mammalian target of rapamycin inhibitors in systemic mastocytosis: A nationwide French pilot study

American journal of hematology, 2024-06, Vol.99 (6), p.1095-1102

2024

Volltextzugriff (PDF)

Indication of autologous stem cell transplantation in chronic inflammatory demyelinating polyneuropathy: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)

Bulletin du cancer, 2020-01, Vol.107 (1S), p.S104

2020

Volltextzugriff (PDF)

Efficacy of antibiotic short course for bloodstream infections in acute myeloid leukemia patients with febrile neutropenia: A retrospective comparative study

The Journal of infection, 2022-01, Vol.84 (1), p.1-7

2022

Volltextzugriff (PDF)

Safety of empirical antibiotic therapy discontinuing for fever of unknown origin during high-risk neutropenia in children

The Journal of infection, 2024-06, Vol.88 (6), p.106171-106171, Article 106171

2024

Volltextzugriff (PDF)

Outcome of febrile neutropenic patients treated for bacteriuria in hematology

Supportive care in cancer, 2023-02, Vol.31 (2), p.102-102, Article 102

2023

Volltextzugriff (PDF)

Late Onset of Chronic Granulomatous Disease Revealed by Paecilomyces lilacinus Cutaneous Infection

Journal of clinical immunology, 2022-01, Vol.42 (1), p.60-63

2022

Volltextzugriff (PDF)

CPX-351 in higher risk myelodysplastic syndrome and chronic myelomonocytic leukaemia: a multicentre, single-arm, phase 2 study

The Lancet. Haematology, 2023-07, Vol.10 (7), p.e521-e529

2023

Volltextzugriff (PDF)

Extending autologous transplantation as first line therapy in multiple myeloma patients with severe renal impairment: a retrospective study by the SFGM-TC

Bone marrow transplantation (Basingstoke), 2018-06, Vol.53 (6), p.749-755

2018

Volltextzugriff (PDF)

Crohn's disease and autologous hemapoietic cell transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)

Bulletin du cancer, 2020-12, Vol.107 (12S), p.S140

2020

Volltextzugriff (PDF)

Long‐term molecular remission in a patient with acute myeloid leukemia harboring a new NUP98‐LEDGF rearrangement

Cancer medicine (Malden, MA), 2019-04, Vol.8 (4), p.1765-1770

2019

Volltextzugriff (PDF)

Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

The Lancet (British edition), 2023-01, Vol.401 (10373), p.269-280

2023

Volltextzugriff (PDF)

A Phase II prospective trial of azacitidine in steroid-dependent or refractory systemic autoimmune/inflammatory disorders and VEXAS syndrome associated with MDS and CMML

Leukemia, 2022-11, Vol.36 (11), p.2739-2742

2022

Volltextzugriff (PDF)

Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study

The Lancet. Haematology, 2020-03, Vol.7 (3), p.e196-e208

2020

Volltextzugriff (PDF)

Safety and Utilization of Midline Catheters in the Management of Acute Myeloid Leukemia: A Single Center Experience

Blood, 2019-11, Vol.134 (Supplement_1), p.5840-5840

2019

Volltextzugriff (PDF)

Prise en charge de la splénomégalie chez les patients atteints de myélofibrose : quelles options en 2020 ?

Hématologie, 2020-10, Vol.26 (5), p.225-228

2020

Volltextzugriff (PDF)

Risk Stratification of Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia Unfit for Intensive Chemotherapy

Blood, 2021-11, Vol.138 (Supplement 1), p.2294-2294

2021

Volltextzugriff (PDF)

L’interféron pour tout patient présentant une polyglobulie de Vaquez ?

Hématologie, 2021-04, Vol.27 (2), p.48-50

2021

Volltextzugriff (PDF)

Leucémie aiguë myéloïde avec mutation FLT3-TKD : bon ou mauvais pronostic ? Analyse du sous-groupe de l’essai RATIFY [1]

Hématologie, 2020-12, Vol.26 (6), p.292-294

2020

Volltextzugriff (PDF)

Molecular Response Analysis By High Throughput Sequencing in Higher Risk Myelodysplastic Syndrome (HR-MDS) Treated Intensively with CPX-351

Blood, 2022-11, Vol.140 (Supplement 1), p.9821-9823

2022

Volltextzugriff (PDF)

Pathophysiologic implications of elevated prevalence of hereditary alpha-tryptasemia in all mastocytosis subtypes

Journal of allergy and clinical immunology, 2024-01, Vol.153 (1), p.349-353.e4

2024

Volltextzugriff (PDF)

CPX 351 As First Line Treatment in Higher Risk MDS. a Phase II Trial By the GFM

Blood, 2021-11, Vol.138 (Supplement 1), p.243-243

2021

Volltextzugriff (PDF)

Vaccinations avant et après greffe de cellules hématopoïétiques autologues chez les patients atteints de maladies auto-immunes : propositions du groupe Maladies Auto-immunes et Thérapie Cellulaire de la SFGM-TC

Bulletin du cancer, 2023-02, Vol.110 (2), p.S97-S107

2023

Volltextzugriff (PDF)

Vaccination before and after autologous hematopoietic cell transplantation for autoimmune diseases: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (MATHEC-SFGM-TC)

Bulletin du cancer, 2023-02, Vol.110 (2S), p.S97

2023

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(43)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(25)
Science & Technology
(25)
Humans
(22)
Female
(11)
Male
(11)
Middle Aged
(11)
Oncology
(11)
Hematology
(10)
Life Sciences
(10)
Aged
(9)
Retrospective Studies
(9)
Adult
(6)
Autologous Hematopoietic Cell Transplantation
(6)
Mutation
(6)
Human Health And Pathology
(4)
Infectious Diseases
(4)
Patients
(4)
Post Autologous Stem Cell Transplantation Follow-Up
(4)
Treatment Outcome
(4)
Urology & Nephrology
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy and safety of mammalian target of rapamycin inhibitors in systemic mastocytosis: A nationwide French pilot study

Indication of autologous stem cell transplantation in chronic inflammatory demyelinating polyneuropathy: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)

Efficacy of antibiotic short course for bloodstream infections in acute myeloid leukemia patients with febrile neutropenia: A retrospective comparative study

Safety of empirical antibiotic therapy discontinuing for fever of unknown origin during high-risk neutropenia in children

Outcome of febrile neutropenic patients treated for bacteriuria in hematology

Late Onset of Chronic Granulomatous Disease Revealed by Paecilomyces lilacinus Cutaneous Infection

CPX-351 in higher risk myelodysplastic syndrome and chronic myelomonocytic leukaemia: a multicentre, single-arm, phase 2 study

Extending autologous transplantation as first line therapy in multiple myeloma patients with severe renal impairment: a retrospective study by the SFGM-TC

Crohn's disease and autologous hemapoietic cell transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)

Long‐term molecular remission in a patient with acute myeloid leukemia harboring a new NUP98‐LEDGF rearrangement

Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

A Phase II prospective trial of azacitidine in steroid-dependent or refractory systemic autoimmune/inflammatory disorders and VEXAS syndrome associated with MDS and CMML

Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study

Safety and Utilization of Midline Catheters in the Management of Acute Myeloid Leukemia: A Single Center Experience

Prise en charge de la splénomégalie chez les patients atteints de myélofibrose : quelles options en 2020 ?

Decitabine Versus Hydroxyurea for Advanced Proliferative Chronic Myelomonocytic Leukemia: Results of a Randomized Phase III Trial Within the EMSCO Network

Risk Stratification of Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia Unfit for Intensive Chemotherapy

L’interféron pour tout patient présentant une polyglobulie de Vaquez ?

Leucémie aiguë myéloïde avec mutation FLT3-TKD : bon ou mauvais pronostic ? Analyse du sous-groupe de l’essai RATIFY [1]

Molecular Response Analysis By High Throughput Sequencing in Higher Risk Myelodysplastic Syndrome (HR-MDS) Treated Intensively with CPX-351

Pathophysiologic implications of elevated prevalence of hereditary alpha-tryptasemia in all mastocytosis subtypes

CPX 351 As First Line Treatment in Higher Risk MDS. a Phase II Trial By the GFM

Prospective validation of a biomarker-driven response prediction model to romiplostim in lower-risk myelodysplastic neoplasms – results of the EUROPE trial by EMSCO

Vaccinations avant et après greffe de cellules hématopoïétiques autologues chez les patients atteints de maladies auto-immunes : propositions du groupe Maladies Auto-immunes et Thérapie Cellulaire de la SFGM-TC

Vaccination before and after autologous hematopoietic cell transplantation for autoimmune diseases: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (MATHEC-SFGM-TC)

Suchergebnisse filtern